Recently, Sharklet was featured on a PBS NewsHour report about superbugs.
Denver’s Channel 7 News, KMGH, ran a story and a short video interview with CEO Mark Spiecker.
Sharklet’s technology could keep dirty devices from making us sick, but it’s not just smartphone surfaces that could benefit.
“In hospitals right now, about 2 million a year get what are called hospital acquired infections. We spend about $30 billion a year treating those,” says Spiecker. “About 100,000 people die a year.”
Last year, Research Scientist Dr. Ethan Mann published a massive study on the performance of Sharklet against competitor anti-microbial technologies. Many outlets picked up on this study, including the Washington Post.
In experiments designed to mimic the transmission of bacteria via both touch and sneezes, the researchers found that Sharklet was more effective than copper, which is one of the most popular anti-microbial surfaces for hospital use. While copper harbored 80 percent less MRSA — antibiotic resistant bacteria — than control surfaces, Sharklet showed reductions of as much as 94 percent.
InnovatioNews published another profile about Sharklet and the company’s expected growth. Be sure to scroll to the bottom of the article to see an interview with our CEO, Mark Spiecker, where he talks about the company at the Rocky Mountain Life Science Investor & Partnering Conference.
“So much of our technology uses chemicals or heavy metals to prevent bacterial growth,” says Mark Spiecker, who joined the company in 2008 and took over as CEO in 2010 when it moved to the Bioscience Park Center incubator.
“We don’t need that. With our surface, if the bacteria can’t attach, they don’t have the chance to grow. We come at that problem from an entirely new angle.”